Primary cardiac angiosarcoma: 53 months' survival after multidisciplinary therapy.
An 8-year-old girl underwent surgical excision of a tumor arising from the right atrium immediately after admission. Because histologic and immunohistochemical examination confirmed the diagnosis of angiosarcoma, adjunctive multidisciplinary therapy was administered for the following 2 years. She is leading a normal school life 53 months after the operation. Therapeutic strategy for this highly malignant cardiac tumor is discussed.
Nakamichi
T
T
Division of Cardiovascular Surgery, Tokyo Metropolitan Kiyose Children's Hospital, Shinjuku, Japan.
Fukuda
T
T
Suzuki
T
T
Kaneko
T
T
Morikawa
Y
Y
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002648:Child; D003131:Combined Modality Therapy; D003606:Dacarbazine / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage / Q000031:analogs & derivatives; D005260:Female; D006338:Heart Neoplasms / Q000188:drug therapy / Q000473:pathology / Q000601:surgery / Q000628:therapy*; D006394:Hemangiosarcoma / Q000188:drug therapy / Q000473:pathology / Q000601:surgery / Q000628:therapy*; D006801:Humans; D007069:Ifosfamide / Q000008:administration & dosage; D017741:Survivors; D013997:Time Factors
D003606:Dacarbazine; D004317:Doxorubicin; C027260:pirarubicin; D007069:Ifosfamide